Our data demonstrates the significant down-regulation of caspase-1 and mature IL-1β protein levels at 100 nM CRID3 concentration (Figure 3) indicating its potential therapeutic role in the prevention of neuronal apoptosis due to the accumulation of Aβ in AD patients. Here, IL1B is linked to Alzheimer disease.